
Journal of Organometallic Chemistry p. 81 - 90 (1997)
Update date:2022-08-03
Topics:
Bezombes, Jean-Philippe
Carre, Francis
Chuit, Claude
Corriu, Robert J. P.
Mehdi, Ahmad
Reye, Catherine
ArPH2 (Ar = [C6H3(CH2NMe2)2-2,6]) 3 undergoes hydride abstraction on treatment with trityl cation to give the stabilized phosphenium ion [ArPH]+BF-4 4a. The same cation was prepared by reaction of 3 with BrCCl3 (4b) and also by lithiation of 3 followed by treatment with I2 (4c). ArLi reacts with PX3 (X = Cl or Br) to give the stabilized phosphenium ion [ArPX]+X- which affords 3 by LiAlH4 reduction. In contrast, DIBAL-H reduction of [ArPX]+X- gives [ArPH]+X-. This last reaction constitutes a transformation of a stabilized and functionalized phosphenium ion into a different ion. Confirmation of the structure of these salts was given by single-crystal X-ray diffraction analysis of [ArPH]+PF-6 4e.
View MoreSuzhou Kangrun Pharmaceutical, Inc
Contact:86-512-63912376,63913329
Address:Building 2, No. 2358 ,Chang'an Rd, Wujiang Economic Development Zone Pioneering park, china
Zhengzhou Yuanli Biological Technology Co., Ltd.
Contact:+86-371-67897870/67897895
Address:No. 38, Qingyang Street, Zhengzhou, Henan, China
Taizhou Crene Biotechnology co.ltd
Contact:86-576-88813233 88205808
Address:Economic Developed Zone of Taizhou Zhejiang China
Contact:+86-371-86058576
Address:NO.32, Jingsan Road, Zhengzhou, China
Suzhou Jingye Medicine & Chemical Co., Ltd
Contact:+86-512-66658588
Address:No. 88, Sanlian Street, Jinfeng Road, Suzhou New District, Jiangsu Province, P. R. China
Doi:10.1007/s12272-012-0805-4
(2012)Doi:10.1016/j.molstruc.2013.11.050
(2014)Doi:10.1080/00397919508012667
(1995)Doi:10.1080/07328319608002369
(1996)Doi:10.1021/jm990148x
(1999)Doi:10.1016/S0020-1693(96)05552-1
(1997)